Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia pneumoniae and atherosclerosis.

Robert J Belland1, Scot P Ouellette, Jens Gieffers

  • 1University of Tennessee Health Sciences Center, 858 Madison Avenue, Memphis, TN 38163, USA. rbelland@utmem.edu

Cellular Microbiology
|January 7, 2004
PubMed
Summary

Chlamydia pneumoniae infection is linked to atherosclerosis, with the bacteria found in lesions and animal models. Antibiotic trials for prevention show mixed results, necessitating further research into its pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPRi and beyond: studying essential gene function in the obligate intracellular bacterium <i>Chlamydia trachomatis</i>.

Journal of bacteriology·2026
Same author

Coordinated topoisomerase function shapes the fluoroquinolone response of <i>Chlamydia trachomatis</i>.

bioRxiv : the preprint server for biology·2026
Same author

Characterization of the cell division-associated peptidoglycan amidase AmiA of <i>Chlamydia trachomatis</i>.

Journal of bacteriology·2026
Same author

Characterization of the Cell Division-Associated Peptidoglycan Amidase AmiA of <i>Chlamydia trachomatis</i>.

bioRxiv : the preprint server for biology·2025
Same author

The second messenger signaling molecule cyclic di-AMP drives developmental cycle progression in <i>Chlamydia trachomatis</i>.

eLife·2025
Same author

The SWIB domain-containing DNA topoisomerase I of <i>Chlamydia trachomatis</i> mediates DNA relaxation.

Journal of bacteriology·2025

Area of Science:

  • Microbiology
  • Cardiovascular Disease Research
  • Infectious Disease Epidemiology

Background:

  • Chlamydia pneumoniae (C. pneumoniae) exposure is common, leading to recurrent respiratory infections.
  • Strong evidence links C. pneumoniae infection to atherosclerosis, including sero-epidemiological data and direct detection in lesions.
  • Animal models demonstrate C. pneumoniae's role in initiating or exacerbating atherosclerotic lesions.

Purpose of the Study:

  • To review the association between C. pneumoniae infection and atherosclerosis.
  • To evaluate the outcomes of human secondary prevention antibiotic treatment trials.
  • To explore the pathogenic mechanisms of C. pneumoniae in cardiovascular disease.

Main Methods:

  • Review of sero-epidemiological studies and clinical trials.

Related Experiment Videos

  • Detection of C. pneumoniae in atherosclerotic lesions using immunohistochemistry, PCR, and electron microscopy.
  • Analysis of C. pneumoniae pathogenesis in cell types relevant to cardiovascular disease.

    • Main Results:

    • Patients with cardiovascular disease show higher anti-C. pneumoniae antibody titers.
    • C. pneumoniae is detected in atherosclerotic lesions but not adjacent normal tissue.
    • Antibiotic treatment trials for secondary prevention have yielded mixed results with no clear long-term benefits.

    Conclusions:

    • C. pneumoniae infects various cardiovascular and respiratory cells, contributing to disease characteristics like inflammation and foam cell formation.
    • Genomic and proteomic analyses are crucial for understanding C. pneumoniae's pathogenic potential.
    • Further research is needed to clarify the role of C. pneumoniae in cardiovascular disease and inform treatment strategies.